Skip to search formSkip to main contentSkip to account menu

indirubin-3'-monoxime

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Oral cancer is the fourth most common cause of death from cancer in Taiwanese men. Indirubin-3′-monoxime (I3M), a potent cyclin… 
2013
2013
Parameters that regulate or affect the cell cycle or the DNA repair choice between non-homologous end-joining and homology… 
2011
2011
Although the antiangiogenic activity of indirubin‐3‐monoxime (I3M), a derivative of a Chinese anti‐leukemia medicine, has been… 
Highly Cited
2010
Highly Cited
2010
Objective—Our goal was to examine the influence of indirubin-3′-monoxime (I3MO), a natural product–derived cyclin-dependent… 
Highly Cited
2007
Highly Cited
2007
Glycogen synthase kinase‐3 (GSK‐3) affects neuropathological events associated with Alzheimeŕs disease (AD) such as… 
Highly Cited
2007
Highly Cited
2007
Pathologic angiogenesis has emerged as an important therapeutic target in several major diseases. Zebrafish offer the potential… 
2006
2006
In traditional Chinese Medicine, the preparation Danggui Longhui Wan has been used for years in the treatment of chronic… 
Highly Cited
2005
Highly Cited
2005
Objective:To evaluate the effects of the cyclin dependent kinase (CDK) inhibitor Indirubin-3′-monoxime (IM) on Tat-mediated… 
Highly Cited
2003
Highly Cited
2003
We have previously examined the specificities of 28 commercially available compounds, reported to be relatively selective… 
Highly Cited
2001
Highly Cited
2001
The bis-indole indirubin is an active ingredient of Danggui Longhui Wan, a traditional Chinese medicine recipe used in the…